ReviewLife (Basel, Switzerland)2023

Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients.

Muttia Amalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.